Cullen/Frost Bankers’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.48M | Sell |
9,463
-4
| -0% | -$600 | 0.01% | 307 |
|
|
2026
Q1 | $1.45M | Sell |
9,467
-55
| -0.6% | -$8.43K | 0.02% | 300 |
|
|
2025
Q4 | $1.31M | Sell |
9,522
-96
| -1% | -$12.6K | 0.01% | 315 |
|
|
2025
Q3 | $1.23M | Sell |
9,618
-876
| -8% | -$107K | 0.01% | 310 |
|
|
2025
Q2 | $1.27M | Buy |
10,494
+827
| +9% | +$93.2K | 0.02% | 295 |
|
|
2025
Q1 | $1.08M | Buy |
9,667
+63
| +0.7% | +$6.71K | 0.02% | 305 |
|
|
2024
Q4 | $935K | Sell |
9,604
-770
| -7% | -$82.1K | 0.01% | 318 |
|
|
2024
Q3 | $1.19M | Sell |
10,374
-347
| -3% | -$39.4K | 0.02% | 285 |
|
|
2024
Q2 | $1.14M | Sell |
10,721
-1,474
| -12% | -$148K | 0.02% | 283 |
|
|
2024
Q1 | $1.18M | Buy |
12,195
+107
| +0.9% | +$11K | 0.02% | 282 |
|
|
2023
Q4 | $1.22M | Sell |
12,088
-10,769
| -47% | -$1.04M | 0.02% | 278 |
|
|
2023
Q3 | $2.33M | Buy |
22,857
+386
| +2% | +$39.2K | 0.04% | 230 |
|
|
2023
Q2 | $2.27M | Sell |
22,471
-793
| -3% | -$79.3K | 0.04% | 237 |
|
|
2023
Q1 | $2.14M | Sell |
23,264
-2,362
| -9% | -$206K | 0.04% | 238 |
|
|
2022
Q4 | $2.32M | Sell |
25,626
-4,285
| -14% | -$361K | 0.04% | 231 |
|
|
2022
Q3 | $2.27M | Buy |
29,911
+220
| +0.7% | +$18.2K | 0.05% | 218 |
|
|
2022
Q2 | $2.51M | Sell |
29,691
-324
| -1% | -$28.4K | 0.06% | 217 |
|
|
2022
Q1 | $2.63M | Sell |
30,015
-1,355
| -4% | -$117K | 0.05% | 224 |
|
|
2021
Q4 | $2.74M | Sell |
31,370
-859
| -3% | -$71.3K | 0.05% | 222 |
|
|
2021
Q3 | $2.64M | Sell |
32,229
-1,619
| -5% | -$146K | 0.05% | 224 |
|
|
2021
Q2 | $3.09M | Sell |
33,848
-5
| -0% | -$445 | 0.06% | 219 |
|
|
2021
Q1 | $2.89M | Sell |
33,853
-5,671
| -14% | -$509K | 0.06% | 218 |
|
|
2020
Q4 | $3.73M | Sell |
39,524
-1,233
| -3% | -$108K | 0.09% | 183 |
|
|
2020
Q3 | $3.54M | Buy |
40,757
+3,277
| +9% | +$284K | 0.09% | 184 |
|
|
2020
Q2 | $3.27M | Buy |
37,480
+976
| +3% | +$84.2K | 0.09% | 185 |
|
|
2020
Q1 | $3.01M | Sell |
36,504
-1,450
| -4% | -$129K | 0.1% | 168 |
|
|
2019
Q4 | $3.59M | Sell |
37,954
-17,685
| -32% | -$1.59M | 0.1% | 176 |
|
|
2019
Q3 | $4.83M | Sell |
55,639
-6,133
| -10% | -$551K | 0.14% | 146 |
|
|
2019
Q2 | $5.64M | Sell |
61,772
-161,980
| -72% | -$13.7M | 0.17% | 133 |
|
|
2019
Q1 | $19.2M | Buy |
223,752
+29,472
| +15% | +$2.37M | 0.59% | 52 |
|
|
2018
Q4 | $14.9M | Sell |
194,280
-72,987
| -27% | -$5.68M | 0.56% | 56 |
|
|
2018
Q3 | $20.6M | Sell |
267,267
-19,525
| -7% | -$1.44M | 0.65% | 51 |
|
|
2018
Q2 | $19.4M | Sell |
286,792
-17,308
| -6% | -$1.19M | 0.6% | 58 |
|
|
2018
Q1 | $22M | Buy |
304,100
+16,411
| +6% | +$1.25M | 0.65% | 51 |
|
|
2017
Q4 | $21.6M | Buy |
287,689
+5,068
| +2% | +$382K | 0.69% | 53 |
|
|
2017
Q3 | $21.7M | Sell |
282,621
-3,608
| -1% | -$272K | 0.71% | 48 |
|
|
2017
Q2 | $21.4M | Sell |
286,229
-7,059
| -2% | -$500K | 0.72% | 46 |
|
|
2017
Q1 | $19.5M | Sell |
293,288
-14,949
| -5% | -$996K | 0.67% | 55 |
|
|
2016
Q4 | $20.1M | Buy |
308,237
+77
| +0% | +$5K | 0.69% | 53 |
|
|
2016
Q3 | $21.8M | Sell |
308,160
-3,410
| -1% | -$248K | 0.78% | 38 |
|
|
2016
Q2 | $23M | Sell |
311,570
-26,793
| -8% | -$1.85M | 0.85% | 28 |
|
|
2016
Q1 | $22M | Sell |
338,363
-1,317
| -0.4% | -$89.6K | 0.82% | 37 |
|
|
2015
Q4 | $26.2M | Buy |
339,680
+2,372
| +0.7% | +$188K | 0.99% | 24 |
|
|
2015
Q3 | $27.8M | Buy |
337,308
+1,249
| +0.4% | +$111K | 1.1% | 15 |
|
|
2015
Q2 | $29.6M | Buy |
336,059
+1,336
| +0.4% | +$123K | 1.1% | 13 |
|
|
2015
Q1 | $29.6M | Sell |
334,723
-1,512
| -0.4% | -$134K | 1.11% | 10 |
|
|
2014
Q4 | $27.9M | Buy |
336,235
+8,711
| +3% | +$722K | 1.07% | 11 |
|
|
2014
Q3 | $27.6M | Buy |
327,524
+232
| +0.1% | +$18.8K | 1.12% | 11 |
|
|
2014
Q2 | $26.6M | Buy |
327,292
+8,971
| +3% | +$706K | 1.07% | 13 |
|
|
2014
Q1 | $24.3M | Buy |
318,321
+13,150
| +4% | +$958K | 1.04% | 13 |
|
|
2013
Q4 | $22M | Buy |
305,171
+33,176
| +12% | +$2.31M | 0.97% | 17 |
|
|
2013
Q3 | $18.7M | Buy |
271,995
+2,059
| +0.8% | +$136K | 0.92% | 18 |
|
|
2013
Q2 | $17.1M | Buy |
+269,936
| New | +$17.6M | 0.9% | 23 |
|
Other funds holding NVS
TAM
SI
Cullen/Frost Bankers's NVS Position: Q2 2026 in Review
Cullen/Frost Bankers reduced its Novartis (NVS) stake by 0.04% in Q2 2026, selling an estimated $600 and leaving 9,463 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #307.
Cullen/Frost Bankers first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.6M in Q2 2015. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Cullen/Frost Bankers held 9,463 shares of Novartis worth $1.48M as of Q2 2026.
- Cullen/Frost Bankers sold 4 Novartis shares in Q2 2026, an estimated $600.
- Novartis made up 0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #307 holding.
- Cullen/Frost Bankers first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Cullen/Frost Bankers's Novartis position peaked at $29.6M in Q2 2015.
- 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.